Astellas
-
Potential losses exceed $300 billion! Nearly 200 drugs are facing a patent cliff
For more reports, please follow DrugTimes
-
The Past and Present of ‘Miraculous Medicine’ Roxadustat
Roxadustat is a domestically produced Class 1 innovative drug originating from the United …
-
科睿唯安交易并购报告 | 2020年第二季度行业纵览与解析
原文始发于微信公众号（科睿唯安生命科学与制药）：科睿唯安交易并购报告 | 2020年第二季度行业纵览与解析 ⬆️欢迎参加2020中国新药CMC高峰论坛！ 交易引领生物制药行业发展 …
